Claritev Corporation (CTEV)vsDoximity Inc (DOCS)
CTEV
Claritev Corporation
$22.71
+11.87%
HEALTHCARE · Cap: $406.74M
DOCS
Doximity Inc
$32.51
-2.02%
HEALTHCARE · Cap: $6.10B
Smart Verdict
WallStSmart Research — data-driven comparison
Claritev Corporation generates 52% more annual revenue ($994.67M vs $655.57M). DOCS leads profitability with a 25.5% profit margin vs -28.5%. DOCS earns a higher WallStSmart Score of 57/100 (C).
CTEV
Hold36
out of 100
Grade: F
DOCS
Buy57
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-85.5%
Fair Value
$11.21
Current Price
$22.71
$11.50 premium
Margin of Safety
+49.1%
Fair Value
$51.05
Current Price
$32.51
$18.54 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Every $100 of equity generates 21 in profit
Keeps 26 of every $100 in revenue as profit
Growing faster than its price suggests
Strong operational efficiency at 21.5%
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -646.0% — below average capital efficiency
Distress zone — elevated risk
Weak financial health signals
Premium valuation, high expectations priced in
Earnings declined 51.9%
Comparative Analysis Report
WallStSmart ResearchBull Case : CTEV
The strongest argument for CTEV centers on Debt/Equity.
Bull Case : DOCS
The strongest argument for DOCS centers on Debt/Equity, Altman Z-Score, Return on Equity. Profitability is solid with margins at 25.5% and operating margin at 21.5%. PEG of 0.59 suggests the stock is reasonably priced for its growth.
Bear Case : CTEV
The primary concerns for CTEV are EPS Growth, Market Cap, Return on Equity.
Bear Case : DOCS
The primary concerns for DOCS are Piotroski F-Score, P/E Ratio, EPS Growth. A P/E of 40.3x leaves little room for execution misses.
Key Dynamics to Monitor
CTEV profiles as a turnaround stock while DOCS is a mature play — different risk/reward profiles.
DOCS carries more volatility with a beta of 1.22 — expect wider price swings.
DOCS is growing revenue faster at 7.3% — sustainability is the question.
CTEV generates stronger free cash flow (55M), providing more financial flexibility.
Bottom Line
DOCS scores higher overall (57/100 vs 36/100), backed by strong 25.5% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Claritev Corporation
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Claritev Corporation, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company is headquartered in New York, New York.
Visit Website →Doximity Inc
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Doximity, Inc. (Ticker: DOCS) is a U.S. healthcare technology company that operates a digital platform tailored for medical professionals. The company’s cloud-based network provides secure communication and collaboration tools, telemedicine services, clinical workflow solutions, and access to medical news, research, and career-management features for physicians, nurse practitioners, physician assistants, and other clinicians. Headquartered in San Francisco, California, Doximity’s Class A common stock trades on the New York Stock Exchange under the ticker DOCS.
Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?